ÂÜÀòÂÒÂ×

Eric Wittchow is an accomplished professional in the field of biomedical research and development, currently serving as Vice President of Research and Development at AMW GmbH since May 2022. Prior to this role, Eric held significant positions including Head of Biodegradables and Drug Elution Technologies at QualiMed Innovative Medizinprodukte GmbH, where responsibilities encompassed leading multifaceted projects and ensuring compliance with regulatory standards throughout the product development lifecycle. Eric has extensive experience in preclinical research, having worked as Director of Translational Research at CVPath Institute and Head of Preclinical Studies at BIOTRONIK AG, where leadership involved expanding preclinical teams and supporting various regulatory approvals. Eric's career also includes roles in medical marketing and liaison management, contributing to notable market share increases and the successful initiation of clinical studies. Eric's academic background includes a doctorate in chemistry obtained from prestigious universities in Germany from 1986 to 1996.